Cytokinetics, Incorporated (CYTK)
NASDAQ · Healthcare
Cytokinetics, Incorporated Total Liabilities 2009–2025
Cytokinetics, Incorporated annual total liabilities history from 2010 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Cytokinetics, Incorporated total liabilities as of December 31, 2025: 2.08B, a 35.60% increase year-over-year.
- Cytokinetics, Incorporated total liabilities for 2025 were 2.08B, a 35.60% increase from 2024.
- Cytokinetics, Incorporated total liabilities for 2024 were 1.54B, a 26.96% increase from 2023.
- Cytokinetics, Incorporated total liabilities for 2023 were 1.21B, a 7.84% increase from 2022.
- Cytokinetics, Incorporated total liabilities for 2022 were 1.12B.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Cytokinetics, Incorporated Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $2,084 |
| 2024 | $1,537 |
| 2023 | $1,211 |
| 2022 | $1,123 |
| 2021 | $597 |
| 2020 | $420 |
| 2019 | $301 |
| 2018 | $185 |
| 2017 | $185 |
| 2016 | $76 |
| 2015 | $47 |
| 2014 | $41 |
| 2013 | $29 |
| 2012 | $7 |
| 2011 | $5 |
Cytokinetics, Incorporated Total Liabilities — FAQ
Cytokinetics, Incorporated (CYTK) total liabilities over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CYTK's total liabilities history?
The chart and table above show Cytokinetics, Incorporated's total liabilities by year and by quarter, including the growth rate.